EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Sudden cardiac death after coronary artery bypass graft surgery and role of antiplatelet therapy

Iftikhar Ali Ch iD, Azhar Chaudhry, Mishal Zehra, Pei-Tzu Wu iD, Mashal Tahirkheli, Poonam Bai, Ananya Bhaktaram, Rahat Jamal, Sabrina Chaudry, Faris Amil, John Randolph, Steven Miller und 2 weitere

PLOS ONE · 25.02.2025 · 20 (2) · e0319292

DOI: 10.1371/journal.pone.0319292 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift PLOS ONE, online erschienen am 25.02.2025. Verfasst von Iftikhar Ali Ch und 13 weiteren Autor:innen. Beteiligte Einrichtung: South Oklahoma Heart Research, Oklahoma City, Oklahoma, United States of America. Hauptthemen laut MEDLINE: Coronary Artery Bypass, Death, Sudden, Cardiac, Platelet Aggregation Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

While coronary artery bypass grafting (CABG) surgery is effective in reducing the risk of myocardial infarction and subsequent cardiac events by improving myocardial perfusion, the risk of sudden cardiac death (SCD) remains notable.

Methods

This retrospective observational study evaluated the efficacy of dual antiplatelet therapy (DAPT) in preventing sudden cardiac death (SCD) among patients undergoing CABG surgery at a major U.S. cardiac center (2012–2015). Data was manually extracted from electronic medical records between 23/04/2017 to 30/03/ 2018 and verified for accuracy, with patients categorized into DAPT or aspirin monotherapy groups based on discharge prescriptions.

Results

Of 2,476 patients followed in this post-CABG study, the analysis included 1,005 patients who received aspirin monotherapy (AMT) and 1,458 patients who received dual antiplatelet therapy (DAPT). AMT group had a significantly higher incidence of SCD compared to those on DAPT (3.1% vs 0.8%; OR = 3.831, 95% CI: 1.961–7.519; p < 0.001). The binary regression model indicated that a higher BMI was associated with an increased risk of SCD (HR = 1.064, 95% CI: 1.012–1.118, p = 0.014). However, patients prescribed P2Y12 antagonists (HR = 0.285, 95% CI: 0.135–0.603, p < 0.001), those with a GFR > 60 ml/min (HR = 0.314, 95% CI: 0.158–0.624, p < 0.001), and those with a higher ejection fraction (HR = 0.962, 95% CI: 0.939–0.986, p = 0.002) were less likely to experience SCD following CABG. A 1 kg/m2 increase in BMI is associated with a 6.4% increase in the risk of SCD. Morbidly obese patients with BMI > 35 were more likely to have experienced SCD than those with BMI < 35 (HR = 2.400, 95% CI: 1.204–4,787; p = 0.013). Similarly, patients with EF > 40% had decreased incidence of SCD compared to those with EF < 40% (HR 0.347, 95% CI:0.158–0.763; p = 0.008). Patients on AMT had higher all-cause (OR = 2.136, 95% CI 1.502–3.038; p < 0.001) and CV mortality (OR = 3.731, 95% CI 2.233–6.235; p < 0.001) but had lower incidence of major bleeding (by drop in hemoglobin criteria) (OR = 0.704, 95% CI: 0.595–0.833; p < 0.001) compared to the DAPT group.

Conclusion

DAPT prescription after CABG improves survival and lowers risk of sudden cardiac death.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery BypassDeath, Sudden, CardiacPlatelet Aggregation InhibitorsHumansMaleFemaleAgedMiddle AgedRetrospective StudiesAspirinRisk Factors

Substanzen

Platelet Aggregation InhibitorsAspirin

Autor:innen und Institutionen

  • South Oklahoma Heart Research, Oklahoma City, Oklahoma, United States of America.
  • SSM Health Saint Anthony Hospital, Oklahoma City, Oklahoma, United States of America.
  • Doctor of Physical Therapy Program, Southern California University of Health Sciences, Whittier, California, United States of America.
  • Oklahoma Heart Hospital, Oklahoma City, Oklahoma, United States of America.

ORCID-Profile: Iftikhar Ali Ch, Pei-Tzu Wu

Zitieren

APA

Ch, I. A., Chaudhry, A., Zehra, M., Wu, P. T., Tahirkheli, M., Bai, P., Bhaktaram, A., Jamal, R., Chaudry, S., Amil, F., Randolph, J., Miller, S., Garrett, J., & Tahirkheli, N. (2025). Sudden cardiac death after coronary artery bypass graft surgery and role of antiplatelet therapy. PLOS ONE, 20(2), e0319292. https://doi.org/10.1371/journal.pone.0319292

Vancouver

Ch IA, Chaudhry A, Zehra M, Wu PT, Tahirkheli M, Bai P, et al. Sudden cardiac death after coronary artery bypass graft surgery and role of antiplatelet therapy. PLOS ONE. 2025;20(2):e0319292. doi:10.1371/journal.pone.0319292

BibTeX
@article{Ch2025,
  author = {Ch, Iftikhar Ali and Chaudhry, Azhar and Zehra, Mishal and Wu, Pei-Tzu and Tahirkheli, Mashal and Bai, Poonam and Bhaktaram, Ananya and Jamal, Rahat and Chaudry, Sabrina and Amil, Faris and Randolph, John and Miller, Steven and Garrett, Jeffrey and Tahirkheli, Naeem},
  title = {Sudden cardiac death after coronary artery bypass graft surgery and role of antiplatelet therapy},
  journal = {PLOS ONE},
  year = {2025},
  volume = {20},
  number = {2},
  pages = {e0319292},
  doi = {10.1371/journal.pone.0319292}
}
Kostenlos starten →